NCT04164199 2026-04-14Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced MalignanciesBeOne MedicinesPhase 3 Active not recruiting404 enrolled
NCT02664935 2025-05-21National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung CancerUniversity of BirminghamPhase 2 Active not recruiting423 enrolled